Workflow
上海君实生物医药科技股份有限公司监事会关于公司2025年A股股票期权激励计划首次授予激励对象名单的公示情况说明及核查意见
Shang Hai Zheng Quan Bao·2025-09-22 18:44

Core Viewpoint - The company has announced the public disclosure and verification of the list of initial incentive recipients for its 2025 A-share stock option incentive plan, which was approved by the board and supervisory committee [2][9]. Disclosure and Verification Process - The company held meetings on September 2, 2025, to approve the stock option incentive plan and related proposals [2]. - The initial list of incentive recipients was publicly disclosed on the Shanghai Stock Exchange website on September 3, 2025, along with the plan draft and summary [2][3]. - A public notice period of 10 days was established from September 3 to September 13, 2025, during which employees could raise objections [3]. - No objections were received by the supervisory committee by the end of the public notice period [4]. Supervisory Committee's Verification - The supervisory committee verified the list of initial incentive recipients, including their qualifications and employment contracts [5]. - The committee confirmed that all listed individuals meet the qualifications as per the Company Law, management regulations, and company charter [6]. - The committee ensured that none of the recipients fell under disqualifying conditions outlined in the management regulations, such as being deemed inappropriate candidates by regulatory bodies within the last 12 months [7][8]. - The basic information of the incentive recipients was verified to be accurate, with no falsehoods or significant omissions [8].